塞力医疗 (603716.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−36.1x

Market Cap

CNY 3.40B

MomentumView details →

1D Return

−4.86%

YTD Return

−15.67%

RSI (14)

54.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−36.1x

Market Cap

CNY 3.40B

RSI (14)

54.8

MomentumView details →

1D Return

−4.86%

YTD Return

−15.67%

ProfitabilityView details →

Gross Margin

22.47%

Net Margin

−21.67%

EBITDA Margin

−11.44%

ROE (TTM)

−20.51%

ROA (TTM)

−12.10%

Asset Turnover

0.55x

GrowthView details →

Revenue YoY

−39.78%

EPS YoY

+8.84%

FCF YoY

—

Revenue CAGR 3Y

−22.44%

EPS CAGR 3Y

+4.59%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.27x

Current Ratio

1.61x

Quick Ratio

1.33x

Div Yield

—

Div Rate

—

Div Growth 1Y

+100.00%

Financials snapshotView financials →

Revenue (TTM)

971.32M

Net Income (TTM)

−210.48M

Op. CF (TTM)

−1.52M

Latest newsMore news →

Saili Medical announced its unaudited 2026 half-year results, reporting a net loss attributable to shareholders of 47.8359 million yuan, compared with a loss of 56.1192 million yuan in the same period last year.9d ago

Similar companies

GRAIL, Inc.GRAL Adicon Holdings Limited09860.HK CareDx, IncCDNA Neogen CorporationNEOG BillionToOne, Inc.BLLN NeoGenomics, Inc.NEO Find similar companies →

Latest newsMore news →

Saili Medical announced its unaudited 2026 half-year results, reporting a net loss attributable to shareholders of 47.8359 million yuan, compared with a loss of 56.1192 million yuan in the same period last year.9d ago